Catalogo Articoli (Spogli Riviste)

HELP
ATTENZIONE: attualmente gli articoli Current Contents (fonte ISI) a partire dall'anno 2002 sono consultabili sulla Risorsa On-Line

Le informazioni sugli articoli di fonte ISI sono coperte da copyright

La ricerca find articoli where soggetti phrase all words 'ANTIDEPRESSANT' sort by level,fasc_key/DESCEND, pagina_ini_num/ASCEND ha restituito 2550 riferimenti
Si mostrano 100 riferimenti a partire da 1
Selezionare un intervallo

Per ulteriori informazioni selezionare i riferimenti di interesse.

    1. Jensen, AG; Hansen, SH
      Separation of hypericins and hyperforins in extracts of Hypericum perforatum L. using non-aqueous capillary electrophoresis with reversed electro-osmotic flow

      JOURNAL OF PHARMACEUTICAL AND BIOMEDICAL ANALYSIS
    2. Schmidt, NB; Wollaway-Bickel, K; Trakowski, JH; Santiago, HT; Vasey, M
      Antidepressant discontinuation in the context of cognitive behavioral treatment for panic disorder

      BEHAVIOUR RESEARCH AND THERAPY
    3. Kerr, GW; McGuffie, AC; Wilkie, S
      Tricyclic antidepressant overdose: a review

      EMERGENCY MEDICINE JOURNAL
    4. Wong, ML; Licinio, J
      Research and treatment approaches to depression

      NATURE REVIEWS NEUROSCIENCE
    5. Kelly, BD
      St John's wort for depression: what's the evidence?

      HOSPITAL MEDICINE
    6. Khan, A; Khan, SR; Leventhal, RM; Brown, WA
      Symptom reduction and suicide risk in patients treated with placebo in antidepressant clinical trials: a replication analysis of the Food and Drug Administration Database

      INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY
    7. Li, WK; Fitzloff, JF
      High performance liquid chromatographic analysis of St. John's Wort with photodiode array detection

      JOURNAL OF CHROMATOGRAPHY B
    8. Dorz, S; Cognolato, S; Conforti, D; Scarso, C; Borgherini, G
      A naturalistic study on the criteria of choice of second-generation antidepressants: A comparison of venlafaxine and SSRIs in depressed inpatients

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    9. Rittmannsberger, H; Wolfl, H
      Pisa syndrome (pleurothotonus) in a polytoxicomanic patient

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    10. Coupland, NJ; Bell, C; Potokar, JP; Bailey, JE; Nutt, DJ
      Cardiovascular reflexes during treatment of social phobia with moclobemide

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    11. Thompson, C
      Managing major depression: improving the interface between psychiatrists and primary care

      INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE
    12. Dzitoyeva, S; Dimitrijevic, N; Manev, H
      Intra-abdominal injection of double-stranded RNA into anesthetized adult Drosophila triggers RNA interference in the central nervous system

      MOLECULAR PSYCHIATRY
    13. Lerer, B; Shapira, B
      Time-dependent sensitization and ECT

      MOLECULAR PSYCHIATRY
    14. Damberg, M; Garpenstrand, H; Hallman, J; Oreland, L
      Genetic mechanisms of behavior - Don't forget about the transcription factors

      MOLECULAR PSYCHIATRY
    15. Butterweck, V; Winterhoff, H; Herkenham, M
      St John's wort, hypericin, and imipramine: a comparative analysis of mRNA levels in brain areas involved in HPA axis control following short-term andlong-term administration in normal and stressed rats

      MOLECULAR PSYCHIATRY
    16. Serretti, A; Zanardi, R; Rossini, D; Cusin, C; Lilli, R; Smeraldi, E
      Influence of tryptophan hydroxylase and serotonin transporter genes on fluvoxamine antidepressant activity

      MOLECULAR PSYCHIATRY
    17. Govoni, S; Racchi, M; Masoero, E; Zamboni, M; Ferini-Strambi, L
      Extrapyramidal symptoms and antidepressant drugs: neuropharmacological aspects of a frequent interaction in the elderly

      MOLECULAR PSYCHIATRY
    18. Perez, J; Tardito, D; Racagni, G; Smeraldi, E; Zanardi, R
      Protein kinase A and Rap1 levels in platelets of untreated patients with major depression

      MOLECULAR PSYCHIATRY
    19. Reus, VI; Wolkowitz, OM
      Antiglucocorticoid drugs in the treatment of depression

      EXPERT OPINION ON INVESTIGATIONAL DRUGS
    20. Shelton, RC
      Antidepressant therapy: new targets for drug development

      EXPERT OPINION ON THERAPEUTIC PATENTS
    21. Shen, H; Numachi, Y; Yoshida, S; Toda, S; Awata, S; Matsuoka, H; Sato, M
      Electroconvulsive shock regulates serotonin transporter mRNA expression inrat raphe nucleus

      PSYCHIATRY AND CLINICAL NEUROSCIENCES
    22. van den Heuvel, MW; Kleijn, HJ; Peeters, PAM
      Bioequivalence trial of orally disintegrating mirtazapine tablets and conventional oral mirtazapine tablets in healthy volunteers

      CLINICAL DRUG INVESTIGATION
    23. Wagstaff, AJ; Ormrod, D; Spencer, CM
      Tianeptine - A review of its use in depressive disorders

      CNS DRUGS
    24. Sonawalla, SB; Fava, M
      Severe depression - Is there a best approach?

      CNS DRUGS
    25. Frank, L; Revicki, DA; Sorensen, SV; Shih, YCT
      The economics of selective serotonin reuptake inhibitors in depression - Acritical review

      CNS DRUGS
    26. Hendricks, JC; Williams, JA; Panckeri, K; Kirk, D; Tello, M; Yin, JCP; Sehgal, A
      A non-circadian role for cAMP signaling and CREB activity in Drosophila rest homeostasis

      NATURE NEUROSCIENCE
    27. Abrams, R
      Modal ECT is effective: Response to letter by Sackeim et al.

      JOURNAL OF ECT
    28. Swartz, CM
      Stimulus dosing in electroconvulsive therapy and the threshold multiple method

      JOURNAL OF ECT
    29. Delva, NJ; Brunet, DG; Hawken, ER; Kesteven, RM; Lawson, JS; Lywood, DW; Rodenburg, M; Waldron, JJ
      Characteristics of responders and nonresponders to brief-pulse right unilateral ECT in a controlled clinical trial

      JOURNAL OF ECT
    30. Rami-Gonzalez, L; Bernardo, M; Boget, T; Salamero, M; Gil-Verona, JA; Junque, C
      Subtypes of memory dysfunction associated with ECT: Characteristics and neurobiological bases

      JOURNAL OF ECT
    31. Swartz, CM
      Inclusion of patients who cannot respond to ECT blocks observation of EEG findings

      JOURNAL OF ECT
    32. Levine, J; Chengappa, KNR; Gershon, S; Drevets, W
      Differentiating primary pathophysiologic from secondary adaptational processes

      DEPRESSION AND ANXIETY
    33. Ringel, BL; Szuba, MR
      Potential mechanisms of the sleep therapies for depression

      DEPRESSION AND ANXIETY
    34. Sanchez-Lacay, JA; Lewis-Fernandez, R; Goetz, D; Blanco, C; Salman, E; Davies, S; Liebowitz, M
      Open trial of nefazodone among Hispanics with major depression: Efficacy, tolerability, and adherence issues

      DEPRESSION AND ANXIETY
    35. Flint, AJ; Rifat, SL
      Nonresponse to first-line pharmacotherapy may predict relapse and recurrence of remitted geriatric depression

      DEPRESSION AND ANXIETY
    36. Weintraub, D
      Nortriptyline toxicity secondary to interaction with bupropion sustained-release

      DEPRESSION AND ANXIETY
    37. Overall, KL
      Pharmacological treatment in behavioural medicine: The importance of neurochemistry, molecular biology and mechanistic hypotheses

      VETERINARY JOURNAL
    38. Panzarino, PJ; Nash, DB
      Cost-effective treatment of depression with selective serotonin reuptake inhibitors

      AMERICAN JOURNAL OF MANAGED CARE
    39. Morrow, TJ
      The pharmacoeconomics of venlafaxine in depression

      AMERICAN JOURNAL OF MANAGED CARE
    40. Armstrong, EP; Abarca, J
      An examination of the relationship between non-depression-related costs and uninterrupted Tx

      FORMULARY
    41. Gadde, KM; Parker, CB; Maner, LG; Wagner, HR; Logue, EJ; Drezner, MK; Krishnan, KRR
      Bupropion for weight loss: An investigation of efficacy and tolerability in overweight and obese women

      OBESITY RESEARCH
    42. McFee, RB; Caraccio, TR; Mofenson, HC
      Selected tricyclic antidepressant ingestions involving children 6 years old or less

      ACADEMIC EMERGENCY MEDICINE
    43. Zimmerman, JL
      Management issues in toxicology

      SEMINARS IN RESPIRATORY AND CRITICAL CARE MEDICINE
    44. Alexopoulos, GS
      "The depression-executive dysfunction syndrome of late life" - A specific target for D-3 agonists?

      AMERICAN JOURNAL OF GERIATRIC PSYCHIATRY
    45. Zarghi, A; Kebriaeezadeh, A; Ahmadkhaniha, R; Akhgari, M; Rastkari, N
      Selective liquid chromatographic method for determination of fluoxetine inplasma

      JOURNAL OF AOAC INTERNATIONAL
    46. Rouleau, F; Asfar, P; Boulet, S; Dube, L; Dupuis, JM; Alquier, P; Victor, J
      Transient ST segment elevation in right precordial leads induced by psychotropic drugs: Relationship to the Brugada syndrome

      JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY
    47. Moresco, RM; Messa, C; Lucignani, G; Rizzo, G; Todde, S; Gilardi, MC; Grimaldi, A; Fazio, F
      Pet in psychopharmacology

      PHARMACOLOGICAL RESEARCH
    48. Tang, KY; Lu, T; Chang, CH; Lo, YK; Cheng, JS; Wang, JL; Chang, HT; Jan, CR
      Effect of fluoxetine on intracellular Ca2+ levels in bladder female transitional carcinoma (BFTC) cells

      PHARMACOLOGICAL RESEARCH
    49. Scandroglio, A; Monferini, E; Borsini, F
      Ex vivo binding of flibanserin to serotonin 5-HT1A and 5-HT2A receptors

      PHARMACOLOGICAL RESEARCH
    50. Smith, DF; Hansen, SB; Ostergaard, L; Gee, AD; Danielsen, E; Ishizu, K; Bender, D; Poulsen, PH; Gjedde, A
      [C-14]serotonin uptake and [O-methyl-C-11]venlafaxine kinetics in porcine brain

      NUCLEAR MEDICINE AND BIOLOGY
    51. Yamato, H; Kannari, K; Shen, H; Suda, T; Matsunaga, M
      Fluoxetine reduces L-DOPA-derived extracellular DA in the 6-OHDA-lesioned rat striatum?

      NEUROREPORT
    52. Venault, P; Rudrauf, D; Lepicard, EM; Berthoz, A; Jouvent, R; Chapouthier, G
      Balance control and posture in anxious mice improved by SSRI treatment

      NEUROREPORT
    53. Cuellar-Quintero, JL; Garcia, DE; Cruzblanca, H
      The antidepressant imipramine inhibits the M-type K+ current in rat sympathetic neurons

      NEUROREPORT
    54. Poutaraud, A; Lobstein, A; Girardin, P; Weniger, B
      Improved procedure for the quality control of Hypericum perforatum L.

      PHYTOCHEMICAL ANALYSIS
    55. Kaneno, S; Fukamauchi, F; Komatsu, H; Koyama, K; Ikawa, K
      Reversal effect of sulpiride on rotational behaviour of rats with unilateral frontal cortex ablation, an alternative explanation for the pharmacological mechanism of its antidepressant effect

      BEHAVIOURAL PHARMACOLOGY
    56. Pallis, E; Thermos, K; Spyraki, C
      Chronic desipramine treatment selectively potentiates somatostatin-induceddopamine release in the nucleus accumbens

      EUROPEAN JOURNAL OF NEUROSCIENCE
    57. Szabo, ST; Blier, P
      Effect of the selective noradrenergic reuptake inhibitor reboxetine on thefiring activity of noradrenaline and serotonin neurons

      EUROPEAN JOURNAL OF NEUROSCIENCE
    58. Hempel, AG; Cormack, TS
      Treatment of the mentally disordered offender

      CURRENT OPINION IN PSYCHIATRY
    59. Rolland, A; Fleurentin, J; Lanhers, MC; Misslin, R; Mortier, F
      Neurophysiological effects of an extract of Eschscholzia californica cham.(Papaveraceae)

      PHYTOTHERAPY RESEARCH
    60. Angelino, AF; Treisman, GJ
      Major depression and demoralization in cancer patients: diagnostic and treatment considerations

      SUPPORTIVE CARE IN CANCER
    61. Dazzi, L; Serra, M; Spiga, F; Pisu, MG; Jentsch, JD; Biggio, G
      Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    62. Gittos, MW; Papp, M
      Antidepressant-like action of AGN 2979, a tryptophan hydroxylase activation inhibitor, in a chronic mild stress model of depression in rats

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    63. Serretti, A; Zanardi, R; Cusin, C; Rossini, D; Lorenzi, C; Smeraldi, E
      Tryptophan hydroxylase gene associated with paroxetine antidepressant activity

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    64. Schreinzer, D; Frey, R; Stimpfl, T; Vycudilik, W; Berzlanovich, A; Kasper, S
      Different fatal toxicity of neuroleptics identified by autopsy

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    65. Correa, H; Duval, F; Claude, MM; Bailey, P; Tremeau, F; Diep, TS; Crocq, MA; Castro, JO
      Noradrenergic dysfunction and antidepressant treatment response

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    66. Kantor, S; Graf, M; Anheuer, ZE; Bagdy, G
      Rapid desensitization of 5-HT1A receptors in Fawn-Hooded rats after chronic fluoxetine treatment

      EUROPEAN NEUROPSYCHOPHARMACOLOGY
    67. Cornblatt, BA; Lencz, T; Kane, JM
      Treatment of the schizophrenia prodrome: is it presently ethical?

      SCHIZOPHRENIA RESEARCH
    68. Butterweck, V; Nishibe, S; Sasaki, T; Uchida, M
      Antidepressant effects of Apocynum venetum leaves in a forced swimming test

      BIOLOGICAL & PHARMACEUTICAL BULLETIN
    69. Matto, V; Vaarmann, A; Allikmets, L
      Apomorphine-induced aggressive behaviour in para-chlorophenylalanine-treated male rats: Implications to brain [H-3]Ketanserin binding and monoamine content

      PHARMACOLOGY & TOXICOLOGY
    70. Ryan, PM; Kelly, JP; Chambers, PL; Leonard, BE
      The toxicity profile of a single dose of paroxetine: An alternative approach to acute toxicity testing in the rat

      PHARMACOLOGY & TOXICOLOGY
    71. Wang, PS; Walker, AM; Tsuang, MT; Orav, EJ; Levin, R; Avorn, J
      Antidepressant use and the risk of breast cancer: A non-association

      JOURNAL OF CLINICAL EPIDEMIOLOGY
    72. Slaughter, JR; Slaughter, KA; Nichols, D; Holmes, SE; Martens, RP
      Prevalence, clinical manifestations, etiology, and treatment of depressionin Parkinson's disease

      JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES
    73. Garfield, DAS; Fichtner, CG; Leveroni, C; Mahableshwarkar, A
      Open trial of nefazodone for combat veterans with posttraumatic stress disorder

      JOURNAL OF TRAUMATIC STRESS
    74. Baker, CB; Woods, SW
      Cost of treatment failure for major depression: Direct costs of continued treatment

      ADMINISTRATION AND POLICY IN MENTAL HEALTH
    75. Gjere, NA
      Psychopharmacology in pregnancy

      JOURNAL OF PERINATAL & NEONATAL NURSING
    76. Dulchin, MC; Oquendo, MA; Malone, KM; Ellis, SP; Li, SH; Mann, JJ
      Prolactin response to dl-fenfluramine challenge before and after treatmentwith paroxetine

      NEUROPSYCHOPHARMACOLOGY
    77. Rush, AJ; Trivedi, MH; Carmody, TJ; Donahue, RMJ; Houser, TL; Bolden-Watson, C; Batey, SR; Ascher, JA; Metz, A
      Response in relation to baseline anxiety levels in major depressive disorder treated with bupropion sustained release or sertraline

      NEUROPSYCHOPHARMACOLOGY
    78. Moreau, X; Jeanningros, R; Mazzola-Pomietto, P
      Chronic effects of triiodothyronine in combination with imipramine on 5-HTtransporter, 5-HT1A and 5-HT2A receptors in adult rat brain

      NEUROPSYCHOPHARMACOLOGY
    79. Turcotte, JE; Debonnel, G; de Montigny, C; Hebert, C; Blier, P
      Assessment of the serotonin and norepinephrine reuptake blocking properties of duloxetine in healthy subjects

      NEUROPSYCHOPHARMACOLOGY
    80. Reneric, JP; Bouvard, M; Stinus, L
      Idazoxan and 8-OH-DPAT modify the behavioral effects induced by either NA,or 5-HT, or dual NA/5-HT reuptake inhibition in the rat forced swimming test

      NEUROPSYCHOPHARMACOLOGY
    81. O'Neill, MF; Conway, MW
      Role of 5-HT1A and 5-HT1B receptors in the mediation of behavior in the forced swim test in mice

      NEUROPSYCHOPHARMACOLOGY
    82. Husum, H; Vasquez, PAJ; Mathe, AA
      Changed concentrations of tachykinins and neuropeptide Y in brain of a ratmodel of depression: Lithium treatment normalizes tachykinins

      NEUROPSYCHOPHARMACOLOGY
    83. Consogno, E; Racagni, G; Popoli, M
      Modifications in brain CaM kinase II after long-term treatment with desmethylimipramine

      NEUROPSYCHOPHARMACOLOGY
    84. Sprouse, J; Braselton, J; Reynolds, L; Clarke, T; Rollema, H
      Activation of postsynaptic 5-HT1A receptors by fluoxetine despite the lossof firing-dependent serotonergic input: Electrophysiological and neurochemical studies

      SYNAPSE
    85. Steffens, DC; Doraiswamy, PM; McQuoid, DR
      Bupropion SR in the naturalistic treatment of elderly patients with major depression

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    86. Mulsant, BH; Alexopoulos, GS; Reynolds, CF; Katz, IR; Abrams, R; Oslin, D; Schulberg, HC
      Pharmacological treatment of depression in older primary care patients: the PROSPECT algorithm

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    87. Yohannes, AM; Connolly, MJ; Baldwin, RC
      A feasibility study of antidepressant drug therapy in depressed elderly patients with chronic obstructive pulmonary disease

      INTERNATIONAL JOURNAL OF GERIATRIC PSYCHIATRY
    88. Dodd, S; Boulton, DW; Burrows, GD; DeVane, CL; Norman, TR
      In vitro metabolism of mirtazapine enantiomers by human cytochrome P450 enzymes

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    89. Toren, P; Eldar, S; Laor, N; Wolmer, L; Samuel, E; Weizman, R
      Fluvoxamine is ineffective in the treatment of enuresis in children and adolescents: an open-label pilot study

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    90. Hindmarch, I
      Expanding the horizons of depression: beyond the monoamine hypothesis

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    91. Miller, FE
      Strategies for the rapid treatment of depression

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    92. Nemets, B; Fux, M; Levine, J; Belmaker, RH
      Combination of antidepressant drugs: The case of inositol

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    93. Paul, IA
      Antidepressant activity and calcium signaling cascades

      HUMAN PSYCHOPHARMACOLOGY-CLINICAL AND EXPERIMENTAL
    94. Gardier, AM; Trillat, AC; Malagie, I; David, D; Hascoet, M; Coombel, MC; Jolliet, P; Jacquot, C; Hen, R; Bourin, M
      5-MT1B receptors mediate the antidepressant effects of selective serotoninreuptake inhibitors.

      COMPTES RENDUS DE L ACADEMIE DES SCIENCES SERIE III-SCIENCES DE LA VIE-LIFE SCIENCES
    95. Uz, T; Manev, H
      Prolonged swim-test immobility of serotonin N-acetyltransferase (AANAT)-mutant mice

      JOURNAL OF PINEAL RESEARCH
    96. MacQueen, GM; Ramakrishnan, K; Croll, SD; Siuciak, JA; Yu, GH; Young, LT; Fahnestock, M
      Performance of heterozygous brain-derived neurotrophic factor knockout mice on behavioral analogues of anxiety, nociception, and depression

      BEHAVIORAL NEUROSCIENCE
    97. Rivas-Vazquez, RA
      Reboxetine: Refocusing on the role of norepinephrine in the treatment of depression

      PROFESSIONAL PSYCHOLOGY-RESEARCH AND PRACTICE
    98. Perfumi, M; Panocka, I; Ciccocioppo, R; Vitali, D; Froldi, R; Massi, M
      Effects of a methanolic extract and a hyperforin-enriched CO2 extract of Hypericum perforatum on alcohol intake in rats

      ALCOHOL AND ALCOHOLISM
    99. Tennyson, H; Levine, N
      Neurotropic and psychotropic drugs in dermatology

      DERMATOLOGIC CLINICS
    100. Mathieu-Nolf, M; Babe, MA; Coquelle-Couplet, V; Billaut, C; Nisse, P; Mathieu, D
      Flumazenil use in an emergency department: A survey

      JOURNAL OF TOXICOLOGY-CLINICAL TOXICOLOGY


ASDD Area Sistemi Dipartimentali e Documentali, Università di Bologna, Catalogo delle riviste ed altri periodici
Documento generato il 18/02/20 alle ore 14:32:39